About GZ Sanli
GZ Sanli is a company founded in 1995. The company has 2,850 employees as of December 31, 2024. GZ Sanli offers products and services including Pediatric Drugs and Respiratory Drugs.
- Employees 2850 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Guizhou Sanli Pharmaceutical Co., Ltd. Class A
-
Annual Revenue
$290.44 M (USD)30.82as on Dec 31, 2024
-
Net Profit
$37.54 M (USD)-6.38as on Dec 31, 2024
-
EBITDA
$54.86 M (USD)30.44as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
2850
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GZ Sanli
GZ Sanli is a publicly listed company on the SSE with ticker symbol 603439 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of GZ Sanli
GZ Sanli offers a comprehensive portfolio of products and services, including Pediatric Drugs and Respiratory Drugs.
Drugs for pediatric use are manufactured and marketed to address child health needs, drawing from traditional Chinese medicine practices
Drugs for respiratory systems are developed and produced to treat related conditions, incorporating modern research methodologies
Funding Insights of GZ Sanli
Investors in GZ Sanli
GZ Sanli has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Cowin Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for GZ Sanli
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GZ Sanli
Investment portfolio details for GZ Sanli
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GZ Sanli
Detailed financials for GZ Sanli
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gz Sanli Comparisons
Peer comparison for GZ Sanli
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GZ Sanli
Detailed competitors of GZ Sanli
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gz Sanli
Complete news archive for GZ Sanli
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GZ Sanli
GZ Sanli was founded in 1995 and raised its 1st funding round 21 years after it was founded.
As of Dec 31, 2024, the latest employee count at GZ Sanli is 2,850.
Annual revenue of GZ Sanli is $290.44M as on Dec 31, 2024.
Manufacturer of traditional Chinese medicine pharmaceuticals. It focuses on pediatric, respiratory, cardiovascular, and digestive internal medicine areas. The company integrates cultivation, research, production, and marketing. A key focus is on developing high-quality drugs with significant therapeutic advantages, particularly for critical illnesses. The company adheres to stringent quality standards and has received numerous industry recognitions. Its commitment is to advancing traditional Chinese medicine through modern techniques while maintaining a focus on patient needs.
GZ Sanli offers Pediatric Drugs and Respiratory Drugs.
Yes, GZ Sanli is publicly traded on SSE under the ticker symbol 603439.
GZ Sanli has 1 investor. Key investors include Cowin Capital.
The ticker symbol of GZ Sanli is 603439 on SSE.